PART I Item 1. Bus iness Overview We are a biopharmaceutical company committed to bringing novel products to patients for the treatment of serious rare and ultra-rare genetic diseases. We have built a diverse portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need and clear biology for treatment, for which there are typically no approved therapies treating the underlying disease. We were founded in April 2010 by our President and Chief Exe...
Q2 FY2026 — expected 2026-09-13
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-18 | 2025-12-31 | 0001193125-26-057329 | EDGAR | 85K words |
| 2025-02-19 | 2024-12-31 | 0000950170-25-023312 | EDGAR | — |
| 2024-02-21 | 2023-12-31 | 0000950170-24-017879 | EDGAR | — |
| 2023-02-17 | 2022-12-31 | 0000950170-23-003096 | EDGAR | — |
| 2022-02-15 | 2021-12-31 | 0000950170-22-001284 | EDGAR | — |
| 2021-02-12 | 2020-12-31 | 0001564590-21-005610 | EDGAR | — |
| 2020-02-14 | 2019-12-31 | 0001564590-20-004667 | EDGAR | — |
| 2019-02-20 | 2018-12-31 | 0001564590-19-003324 | EDGAR | — |
| 2018-02-21 | 2017-12-31 | 0001564590-18-002535 | EDGAR | — |
| 2017-02-17 | 2016-12-31 | 0001564590-17-001714 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-05 | 2026-06-30 | 0001193125-26-333233 | EDGAR | — |
| 2025-11-05 | 2025-09-30 | 0001193125-25-265126 | EDGAR | 55K words |
| 2025-08-06 | 2025-06-30 | 0000950170-25-103290 | EDGAR | — |
| 2025-05-07 | 2025-03-31 | 0000950170-25-064726 | EDGAR | — |
| 2024-11-06 | 2024-09-30 | 0000950170-24-121679 | EDGAR | — |
| 2024-08-02 | 2024-06-30 | 0000950170-24-089488 | EDGAR | — |
| 2024-05-03 | 2024-03-31 | 0000950170-24-052346 | EDGAR | — |
| 2023-11-03 | 2023-09-30 | 0000950170-23-058427 | EDGAR | — |
| 2023-08-04 | 2023-06-30 | 0000950170-23-038173 | EDGAR | — |
| 2023-05-05 | 2023-03-31 | 0000950170-23-018017 | EDGAR | — |
| 2022-11-03 | 2022-09-30 | 0000950170-22-021366 | EDGAR | — |
| 2022-07-29 | 2022-06-30 | 0000950170-22-013411 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-11 | 0001193125-26-343525 | EDGAR | — |
| 2026-08-04 | 0001193125-26-332802 | EDGAR | — |
| 2026-04-02 | 0001193125-26-139084 | EDGAR | 1K words |
| 2026-03-30 | 0001193125-26-130498 | EDGAR | — |
| 2026-03-12 | 0001193125-26-103167 | EDGAR | — |
| 2026-02-23 | 0001193125-26-062568 | EDGAR | — |
| 2026-02-12 | 0001193125-26-048738 | EDGAR | — |
| 2026-02-03 | 0001193125-26-034474 | EDGAR | — |
| 2026-01-30 | 0001193125-26-030590 | EDGAR | — |
| 2026-01-12 | 0001193125-26-009791 | EDGAR | — |
269 total filings indexed. 237 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001515673 |
| Ticker | RARE |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.ultragenyx.com |
| Listed | 2014-01-31 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/RARE (~200 tokens, structured JSON with cryptographic provenance)